<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">35046043</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>119</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>25</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Molecular basis of differential receptor usage for naturally occurring CD55-binding and -nonbinding coxsackievirus B3 strains.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e2118590119</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.2118590119</ELocationID><Abstract><AbstractText>Receptor usage defines cell tropism and contributes to cell entry and infection. Coxsackievirus B (CVB) engages coxsackievirus and adenovirus receptor (CAR), and selectively utilizes the decay-accelerating factor (DAF; CD55) to infect cells. However, the differential receptor usage mechanism for CVB remains elusive. This study identified VP3-234 residues (234Q/N/V/D/E) as critical population selection determinants during CVB3 virus evolution, contributing to diverse binding affinities to CD55. Cryoelectron microscopy (cryo-EM) structures of CD55-binding/nonbinding isolates and their complexes with CD55 or CAR were obtained under both neutral and acidic conditions, and the molecular mechanism of VP3-234 residues determining CD55 affinity/specificity for naturally occurring CVB3 strains was elucidated. Structural and biochemical studies in vitro revealed the dynamic entry process of CVB3 and the function of the uncoating receptor CAR with different pH preferences. This work provides detailed insight into the molecular mechanism of CVB infection and contributes to an in-depth understanding of enterovirus attachment receptor usage.</AbstractText><CopyrightInformation>Copyright © 2022 the Author(s). Published by PNAS.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qingling</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, City University of Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing 100101, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shaanxi Natural Carbohydrate Resource Engineering Research Center, College of Food Science and Technology, Northwest University, Xi'an 710069, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>World Health Organization Western Pacific Region (WHO WPRO) Regional Polio Reference Laboratory and National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Congcong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Cryo-EM Centre, Department of Biology, Southern University of Science and Technology, Shenzhen 518055, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen 518112, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Guoqing</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pathogenobiology, The Key Laboratory of Zoonosis, Chinese Ministry of Education, College of Basic Medical Science, Jilin University, Changchun 130021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Hao</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-2811-0370</Identifier><AffiliationInfo><Affiliation>Research Network of Immunity and Health, Beijing Institutes of Life Science, Chinese Academy of Sciences, Beijing 100101, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shang</LastName><ForeName>Guijun</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Shanxi Academy of Advanced Research and Innovation, Taiyuan 030032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Ruchao</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-2741-6212</Identifier><AffiliationInfo><Affiliation>CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing 100101, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qu</LastName><ForeName>Xiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing 100101, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Sheng</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing 100101, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Yingzi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing 100101, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Peiyi</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Cryo-EM Centre, Department of Biology, Southern University of Science and Technology, Shenzhen 518055, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Wenbo</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>World Health Organization Western Pacific Region (WHO WPRO) Regional Polio Reference Laboratory and National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing 100101, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Jianxun</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-9358-4732</Identifier><AffiliationInfo><Affiliation>CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing 100101, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Mengsu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, City University of Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>George F</ForeName><Initials>GF</Initials><Identifier Source="ORCID">0000-0002-3869-615X</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, City University of Hong Kong, Hong Kong SAR, China; gaof@im.ac.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing 100101, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>001</GrantID><Acronym>WHO_</Acronym><Agency>World Health Organization</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018958">CD55 Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011991">Receptors, Virus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C105941">coxsackievirus B receptor</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019943" MajorTopicYN="N">Amino Acid Substitution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018958" MajorTopicYN="N">CD55 Antigens</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="N">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="Y">Host-Pathogen Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054730" MajorTopicYN="N">Protein Interaction Domains and Motifs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011991" MajorTopicYN="N">Receptors, Virus</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013329" MajorTopicYN="N">Structure-Activity Relationship</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053585" MajorTopicYN="N">Virus Attachment</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">attachment or uncoating</Keyword><Keyword MajorTopicYN="N">cryo-EM</Keyword><Keyword MajorTopicYN="N">differential receptor usage</Keyword><Keyword MajorTopicYN="N">enteroviruses</Keyword><Keyword MajorTopicYN="N">entry</Keyword></KeywordList><CoiStatement>The authors declare no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>20</Day><Hour>5</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35046043</ArticleId><ArticleId IdType="pmc">PMC8794823</ArticleId><ArticleId IdType="doi">10.1073/pnas.2118590119</ArticleId><ArticleId IdType="pii">2118590119</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lugo D., Krogstad P., Enteroviruses in the early 21st century: New manifestations and challenges. Curr. Opin. Pediatr. 28, 107–113 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4750492</ArticleId><ArticleId IdType="pubmed">26709690</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaaloul I., et al. , Coxsackievirus B detection in cases of myocarditis, myopericarditis, pericarditis and dilated cardiomyopathy in hospitalized patients. Mol. Med. Rep. 10, 2811–2818 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4227425</ArticleId><ArticleId IdType="pubmed">25241846</ArticleId></ArticleIdList></Reference><Reference><Citation>Vehik K., et al. , TEDDY Study Group, Prospective virome analyses in young children at increased genetic risk for type 1 diabetes. Nat. Med. 25, 1865–1872 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6898786</ArticleId><ArticleId IdType="pubmed">31792456</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyöty H., Leon F., Knip M., Developing a vaccine for type 1 diabetes by targeting coxsackievirus B. Expert Rev. Vaccines 17, 1071–1083 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30449209</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong A. H., Lau C. S., Cheng P. K., Ng A. Y., Lim W. W., Coxsackievirus B3-associated aseptic meningitis: An emerging infection in Hong Kong. J. Med. Virol. 83, 483–489 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21264869</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Z., et al. , Two coxsackievirus B3 outbreaks associated with hand, foot, and mouth disease in China and the evolutionary history worldwide. BMC Infect. Dis. 19, 466 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6534883</ArticleId><ArticleId IdType="pubmed">31126252</ArticleId></ArticleIdList></Reference><Reference><Citation>Abedi G. R., Watson J. T., Nix W. A., Oberste M. S., Gerber S. I., Enterovirus and parechovirus surveillance—United States, 2014–2016. MMWR Morb. Mortal. Wkly. Rep. 67, 515–518 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5944979</ArticleId><ArticleId IdType="pubmed">29746455</ArticleId></ArticleIdList></Reference><Reference><Citation>Calderón K. I., et al. , Molecular epidemiology of coxsackievirus B3 infection in Spain, 2004–2014. Arch. Virol. 161, 1365–1370 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26898312</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossmann M. G., He Y., Kuhn R. J., Picornavirus-receptor interactions. Trends Microbiol. 10, 324–331 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12110211</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergelson J. M., Coyne C. B., Picornavirus entry. Adv. Exp. Med. Biol. 790, 24–41 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23884584</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X., et al. , Human neonatal Fc receptor is the cellular uncoating receptor for enterovirus B. Cell 177, 1553–1565.e16 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7111318</ArticleId><ArticleId IdType="pubmed">31104841</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y., et al. , Molecular basis of coxsackievirus A10 entry using the two-in-one attachment and uncoating receptor KRM1. Proc. Natl. Acad. Sci. U.S.A. 117, 18711–18718 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7414063</ArticleId><ArticleId IdType="pubmed">32690697</ArticleId></ArticleIdList></Reference><Reference><Citation>Strauss M., et al. , Nectin-like interactions between poliovirus and its receptor trigger conformational changes associated with cell entry. J. Virol. 89, 4143–4157 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4442392</ArticleId><ArticleId IdType="pubmed">25631086</ArticleId></ArticleIdList></Reference><Reference><Citation>Milstone A. M., et al. , Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate. J. Virol. 79, 655–660 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC538729</ArticleId><ArticleId IdType="pubmed">15596863</ArticleId></ArticleIdList></Reference><Reference><Citation>Carson S. D., Kinetic models for receptor-catalyzed conversion of coxsackievirus B3 to A-particles. J. Virol. 88, 11568–11575 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4178797</ArticleId><ArticleId IdType="pubmed">25078690</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K., et al. , Structures of echovirus 30 in complex with its receptors inform a rational prediction for enterovirus receptor usage. Nat. Commun. 11, 4421 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7474057</ArticleId><ArticleId IdType="pubmed">32887891</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J., Thibaut H. J., Strating J. R. P. M., van Kuppeveld F. J. M., The life cycle of non-polio enteroviruses and how to target it. Nat. Rev. Microbiol. 16, 368–381 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeiffer J. K., Kirkegaard K., Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice. PLoS Pathog. 1, e11 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1250929</ArticleId><ArticleId IdType="pubmed">16220146</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Pfeiffer J. K., Emergence of a large-plaque variant in mice infected with coxsackievirus B3. mBio 7, e00119 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4817249</ArticleId><ArticleId IdType="pubmed">27025249</ArticleId></ArticleIdList></Reference><Reference><Citation>Vignuzzi M., Stone J. K., Arnold J. J., Cameron C. E., Andino R., Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 439, 344–348 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1569948</ArticleId><ArticleId IdType="pubmed">16327776</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan J., et al. , Single amino acid changes in the virus capsid permit coxsackievirus B3 to bind decay-accelerating factor. J. Virol. 85, 7436–7443 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3126562</ArticleId><ArticleId IdType="pubmed">21561916</ArticleId></ArticleIdList></Reference><Reference><Citation>Novoselov A. V., et al. , A single amino acid substitution controls DAF-dependent phenotype of echovirus 11 in rhabdomyosarcoma cells. Virus Res. 166, 87–96 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22445689</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne C. B., Bergelson J. M., Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell 124, 119–131 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16413486</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D., et al. , Unexpected mode of engagement between enterovirus 71 and its receptor SCARB2. Nat. Microbiol. 4, 414–419 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30531980</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu S., et al. , Molecular and structural basis of echovirus 11 infection by using the dual-receptor system of CD55 and FcRn [in Chinese]. Chin. Sci. Bull. 65, 67–79 (2020).</Citation></Reference><Reference><Citation>Xu L., et al. , Cryo-EM structures reveal the molecular basis of receptor-initiated coxsackievirus uncoating. Cell Host Microbe 29, 448–462.e5 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8310385</ArticleId><ArticleId IdType="pubmed">33539764</ArticleId></ArticleIdList></Reference><Reference><Citation>Kallewaard N. L., et al. , Tissue-specific deletion of the coxsackievirus and adenovirus receptor protects mice from virus-induced pancreatitis and myocarditis. Cell Host Microbe 6, 91–98 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2761025</ArticleId><ArticleId IdType="pubmed">19616768</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan J., Zhang L., Organtini L. J., Hafenstein S., Bergelson J. M., Specificity of coxsackievirus B3 interaction with human, but not murine, decay-accelerating factor: Replacement of a single residue within short consensus repeat 2 prevents virus attachment. J. Virol. 89, 1324–1328 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4300647</ArticleId><ArticleId IdType="pubmed">25392210</ArticleId></ArticleIdList></Reference><Reference><Citation>Dho S. H., Lim J. C., Kim L. K., Beyond the role of CD55 as a complement component. Immune Netw. 18, e11 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5833118</ArticleId><ArticleId IdType="pubmed">29503741</ArticleId></ArticleIdList></Reference><Reference><Citation>Dho S. H., et al. , A novel therapeutic anti-CD55 monoclonal antibody inhibits the proliferation and metastasis of colorectal cancer cells. Oncol. Rep. 42, 2686–2693 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31578581</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H., Hara H., Cooper D. K. C., The complex functioning of the complement system in xenotransplantation. Xenotransplantation 26, e12517 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6717021</ArticleId><ArticleId IdType="pubmed">31033064</ArticleId></ArticleIdList></Reference><Reference><Citation>Detsika M. G., et al. , Induction of decay accelerating factor and membrane cofactor protein by resveratrol attenuates complement deposition in human coronary artery endothelial cells. Biochem. Biophys. Rep. 19, 100652 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6541742</ArticleId><ArticleId IdType="pubmed">31193778</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii K., et al. , VP1 amino acid residue 145 of enterovirus 71 is a key residue for its receptor attachment and resistance to neutralizing antibody during cynomolgus monkey infection. J. Virol. 92, e00682-18 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6052295</ArticleId><ArticleId IdType="pubmed">29848582</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K., et al. , Amino acid variation at VP1-145 of enterovirus 71 determines attachment receptor usage and neurovirulence in human scavenger receptor B2 transgenic mice. J. Virol. 92, e00681-18 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6052303</ArticleId><ArticleId IdType="pubmed">29848584</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y., et al. , Enterovirus 71 binding to PSGL-1 on leukocytes: VP1-145 acts as a molecular switch to control receptor interaction. PLoS Pathog. 9, e1003511 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3723564</ArticleId><ArticleId IdType="pubmed">23935488</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel K. P., Coyne C. B., Bergelson J. M., Dynamin- and lipid raft-dependent entry of decay-accelerating factor (DAF)-binding and non-DAF-binding coxsackieviruses into nonpolarized cells. J. Virol. 83, 11064–11077 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2772800</ArticleId><ArticleId IdType="pubmed">19710132</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung S. K., et al. , Internalization and trafficking mechanisms of coxsackievirus B3 in HeLa cells. Virology 333, 31–40 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15708590</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng S. Q., et al. , MotionCor2: Anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331–332 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5494038</ArticleId><ArticleId IdType="pubmed">28250466</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohou A., Grigorieff N., CTFFIND4: Fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 192, 216–221 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6760662</ArticleId><ArticleId IdType="pubmed">26278980</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludtke S. J., Baldwin P. R., Chiu W., EMAN: Semiautomated software for high-resolution single-particle reconstructions. J. Struct. Biol. 128, 82–97 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10600563</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettersen E. F., et al. , UCSF Chimera—A visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15264254</ArticleId></ArticleIdList></Reference><Reference><Citation>Emsley P., Cowtan K., Coot: Model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15572765</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams P. D., et al. , PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213–221 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2815670</ArticleId><ArticleId IdType="pubmed">20124702</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>